Literature DB >> 3787286

Gram-negative bacillary meningitis in the adult: review of 39 cases.

D J Gower, A A Barrows, D L Kelly, S Pegram.   

Abstract

From 1976 through 1984, the period covered in this report, we reviewed our total experience with gram-negative meningitis in adult patients, looking especially at how treatment and mortality had changed. Thirty-nine adults had 45 episodes of gram-negative meningitis. Twenty-five patients had had a dura-arachnoid disruption, 12 a septic episode, and two a bacterial mastoiditis. The overall mortality was 35.9%. Thirteen patients were treated with a full course of intrathecal antibiotics (five or more days) and eight patients with an abbreviated course (one or two doses). The use of chloramphenicol was associated with poor patient outcome, a finding consistent with both experimental and clinical findings of others.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3787286     DOI: 10.1097/00007611-198612000-00007

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  [Acute meningitis after transrectal prostate biopsy].

Authors:  F Meisel; C Jacobi; R Kollmar; A Hug; M Schwaninger; S Schwab
Journal:  Urologe A       Date:  2003-12       Impact factor: 0.639

Review 2.  Central nervous system infections: a critical care approach.

Authors:  W C Ziai; R G Geocadin
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 6.030

3.  Spontaneous gram-negative bacillary meningitis in adult patients: characteristics and outcome.

Authors:  Virginia Pomar; Natividad Benito; Joaquin López-Contreras; Pere Coll; Mercedes Gurguí; Pere Domingo
Journal:  BMC Infect Dis       Date:  2013-09-30       Impact factor: 3.090

4.  Community-acquired adult Escherichia coli meningitis leading to diagnosis of unrecognized retropharyngeal abscess and cervical spondylodiscitis: a case report.

Authors:  Rebekka Kohlmann; Andrey Nefedev; Martin Kaase; Sören G Gatermann
Journal:  BMC Infect Dis       Date:  2015-12-12       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.